PropertyValue
?:author
?:datePublished
  • 2011-05-10 (xsd:date)
?:headline
  • Baby Orajel Warning (en)
?:inLanguage
?:itemReviewed
?:mentions
?:reviewBody
  • Example: [Collected via e-mail, July 2008] In April 2011, the U.S. Food and Drug Administration (FDA) issued a safety announcement confirming the account described above, warning that in rare cases the use of benzocaine (commonly found in over-the-counter gels and liquids used for teething pain in infants) can result in a condition known as methemoglobinemia, symptoms of which include shortness of breath and blue skin: Additional information: (en)
?:reviewRating
rdf:type
?:url